DE10203086A1 - 5-Ring Heterozyklen - Google Patents

5-Ring Heterozyklen

Info

Publication number
DE10203086A1
DE10203086A1 DE10203086A DE10203086A DE10203086A1 DE 10203086 A1 DE10203086 A1 DE 10203086A1 DE 10203086 A DE10203086 A DE 10203086A DE 10203086 A DE10203086 A DE 10203086A DE 10203086 A1 DE10203086 A1 DE 10203086A1
Authority
DE
Germany
Prior art keywords
alkyl
group
substituted
optionally
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10203086A
Other languages
German (de)
English (en)
Inventor
Tobias Wunberg
Ulrich Betz
Gerald Kleymann
Susanne Nikolic
Juergen Reefschlaeger
Rudolf Schohe-Loop
Holger Zimmermann
Franz Zumpe
Wolfgang Bender
Kerstin Henninger
Guy Hewlett
Axel Jensen
Joerg Keldenich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to DE10203086A priority Critical patent/DE10203086A1/de
Priority to AU2003239243A priority patent/AU2003239243A1/en
Priority to PCT/EP2003/000376 priority patent/WO2003064394A1/fr
Priority to CA002474456A priority patent/CA2474456A1/fr
Priority to JP2003564017A priority patent/JP2005521669A/ja
Priority to EP03734671A priority patent/EP1472229A1/fr
Publication of DE10203086A1 publication Critical patent/DE10203086A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE10203086A 2002-01-28 2002-01-28 5-Ring Heterozyklen Withdrawn DE10203086A1 (de)

Priority Applications (6)

Application Number Priority Date Filing Date Title
DE10203086A DE10203086A1 (de) 2002-01-28 2002-01-28 5-Ring Heterozyklen
AU2003239243A AU2003239243A1 (en) 2002-01-28 2003-01-16 5-ring heterocycles used as antiviral agents
PCT/EP2003/000376 WO2003064394A1 (fr) 2002-01-28 2003-01-16 Heterocycles pentagonaux utilises en tant qu'agents antiviraux
CA002474456A CA2474456A1 (fr) 2002-01-28 2003-01-16 Heterocycles pentagonaux utilises en tant qu'agents antiviraux
JP2003564017A JP2005521669A (ja) 2002-01-28 2003-01-16 抗ウイルス剤として使用するための５員ヘテロ環
EP03734671A EP1472229A1 (fr) 2002-01-28 2003-01-16 Heterocycles pentagonaux utilises en tant qu'agents antiviraux

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10203086A DE10203086A1 (de) 2002-01-28 2002-01-28 5-Ring Heterozyklen

Publications (1)

Publication Number Publication Date
DE10203086A1 true DE10203086A1 (de) 2003-07-31

Family

ID=7713161

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10203086A Withdrawn DE10203086A1 (de) 2002-01-28 2002-01-28 5-Ring Heterozyklen

Country Status (6)

Country Link
EP (1) EP1472229A1 (fr)
JP (1) JP2005521669A (fr)
AU (1) AU2003239243A1 (fr)
CA (1) CA2474456A1 (fr)
DE (1) DE10203086A1 (fr)
WO (1) WO2003064394A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1797037E (pt) * 2004-09-29 2015-03-17 Bayer Healthcare Llc Processo para a preparação de 4-{4-[({[4-cloro-3- (trifluorometil)-fenil]-amino}-carbonil)-amino]-fenoxi}-nmetilpiridina- 2-carboxamida
WO2014130582A2 (fr) * 2013-02-19 2014-08-28 Senomyx, Inc. Composés utiles comme modulateurs de trpm8

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES482789A0 (es) * 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
WO1997021707A1 (fr) * 1995-12-14 1997-06-19 Merck & Co., Inc. Antagonistes de la gonadoliberine
JP2001526222A (ja) * 1997-12-22 2001-12-18 バイエル コーポレイション アリールおよびヘテロアリール置換複素環尿素を使用するｐ３８キナーゼ活性の阻害

Also Published As

Publication number Publication date
WO2003064394A1 (fr) 2003-08-07
JP2005521669A (ja) 2005-07-21
EP1472229A1 (fr) 2004-11-03
AU2003239243A1 (en) 2003-09-02
CA2474456A1 (fr) 2003-08-07
WO2003064394A8 (fr) 2003-12-24

Similar Documents

Publication Publication Date Title
EP0738722A1 (fr) Dérivés d'acides 5-amino-benzofuran-2-carboxyliques
EP1853582B1 (fr) Imidazoles substitues par heterocyclylamide
DE10257358A1 (de) Substituierte Pyrrole
EP1751155A1 (fr) Azachinazolines substituees a action antivirale
EP1625129B1 (fr) Dihydroquinazolines substituees par heterocyclyle et leur utilisation comme antiviraux
DE10201240A1 (de) Substituierte Alkyluracile und ihre Verwendung
EP1732901B1 (fr) Composes imidazole a substitution 4-aminocarbonylamino a activite antivirale
DE10305785A1 (de) Dihydrochinazoline
DE10203086A1 (de) 5-Ring Heterozyklen
WO2004041790A1 (fr) Quinazolines substituees utilisees comme agents antiviraux, en particulier contre des cytomegalovirus
EP1910330B1 (fr) Thiazoles, pyrroles et thiophenes substitués par un hétérocyclylamide
EP1583967B1 (fr) Procede pour inhiber la replication de virus herpetiques
DE10034801A1 (de) Substituierte Amidoalkyl-uracile und ihre Verwendung
DE10222024A1 (de) Lactame
DE10217518A1 (de) Lactone
DE10257786A1 (de) Oxazolidinone

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: BAYER HEALTHCARE AG, 51373 LEVERKUSEN, DE

8139 Disposal/non-payment of the annual fee